Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report

Front Immunol. 2020 Nov 24:11:603428. doi: 10.3389/fimmu.2020.603428. eCollection 2020.

Abstract

In this work we present the case of SARS-CoV-2 infection in a 1.5-year-old boy affected by severe Wiskott-Aldrich Syndrome with previous history of autoinflammatory disease, occurring 5 months after treatment with gene therapy. Before SARS-CoV-2 infection, the patient had obtained engraftment of gene corrected cells, resulting in WASP expression restoration and early immune reconstitution. The patient produced specific immunoglobulins to SARS-CoV-2 at high titer with neutralizing capacity and experienced a mild course of infection, with limited inflammatory complications, despite pre-gene therapy clinical phenotype.

Keywords: Wiskott-Aldrich Syndrome; gene therapy; immune reconstitution; primary immunodeficiencies; severe acute respiratory syndrome Coronavirus 2 (2019-nCoV).

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Neutralizing* / blood
  • Antibodies, Neutralizing* / immunology
  • Antibodies, Viral* / blood
  • Antibodies, Viral* / immunology
  • COVID-19* / blood
  • COVID-19* / immunology
  • COVID-19* / therapy
  • Genetic Therapy*
  • Humans
  • Infant
  • Male
  • SARS-CoV-2* / immunology
  • SARS-CoV-2* / metabolism
  • Wiskott-Aldrich Syndrome Protein / biosynthesis
  • Wiskott-Aldrich Syndrome Protein / immunology
  • Wiskott-Aldrich Syndrome* / blood
  • Wiskott-Aldrich Syndrome* / immunology
  • Wiskott-Aldrich Syndrome* / therapy

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • WAS protein, human
  • Wiskott-Aldrich Syndrome Protein